|
|
Achievement of at least very good partial response is a simple and robust prognostic factor in patients with multiple myeloma treated with high-dose therapy: long-term analysis of the IFM 99-02 and 99-04 Trials.
Jean-Luc Harousseau
,
Herve Avet-Loiseau
,
Michel Attal
,
Catherine Charbonnel
,
Frederic Garban
,
et al.
Journal articles
hal-00821143v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Chromosomal abnormalities are major prognostic factors in elderly patients with multiple myeloma: the intergroupe francophone du myélome experience
Hervé Avet-Loiseau
,
Cyrille Hulin
,
Loic Campion
,
Philippe Rodon
,
Gerald Marit
,
et al.
Journal articles
hal-01064339v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Mauricette Michallet
,
Quoc-Hung Le
,
Mohamad Mohty
,
Thomas Prébet
,
Franck Nicolini
,
et al.
Journal articles
inserm-00484237v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Long-term follow-up results of IFM99-03 and IFM99-04 trials comparing nonmyeloablative allotransplantation with autologous transplantation in high-risk de novo multiple myeloma.
Philippe Moreau
,
Frédéric Garban
,
Michel Attal
,
Mauricette Michallet
,
Gérald Marit
,
et al.
Journal articles
hal-00821148v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Deciphering the chronology of copy number alterations in Multiple Myeloma
Anil Aktas Samur
,
Stephane Minvielle
,
Masood Shammas
,
Mariateresa Fulciniti
,
Florence Magrangeas
,
et al.
Journal articles
inserm-02290251v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
A Genome-Wide Association Study Identifies a Novel Locus for Bortezomib-Induced Peripheral Neuropathy in European Multiple Myeloma Patients
Florence Magrangeas
,
Rowan Kuiper
,
Hervé Avet-Loiseau
,
Wilfried Gouraud
,
Catherine Guérin-Charbonnel
,
et al.
Journal articles
inserm-01313506v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Pomalidomide plus low-dose dexamethasone is active and well tolerated in bortezomib and lenalidomide-refractory multiple myeloma: Intergroupe Francophone du Myélome 2009-02
Xavier Leleu
,
Michel Attal
,
Bertrand Arnulf
,
Philippe Moreau
,
Catherine Traulle
,
et al.
Journal articles
hal-01064417v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|
|
|
Lenalidomide maintenance after stem-cell transplantation for multiple myeloma.
Michel Attal
,
Valerie Lauwers-Cances
,
Gerald Marit
,
Denis Caillot
,
Philippe Moreau
,
et al.
Journal articles
hal-00852275v1
|
Share
Gmail
Facebook
Twitter
LinkedIn
More
|